As of 2025-09-17, the Relative Valuation of Homology Medicines Inc (FIXX) is (731.56) USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.55 USD, the upside of Homology Medicines Inc based on Relative Valuation is -3079.9%.
The range of the Relative Valuation is (576.76) - (965.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 11.4x | 7.9x |
| Forward P/E multiples | 6.8x - 11.9x | 9.4x |
| Fair Price | (576.76) - (965.23) | (731.56) |
| Upside | -2449.3% - -4031.7% | -3079.9% |
| Date | P/E |